| Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
|---|
| 07/18/2000 | US6090579 Human SDR2 cDNA clone |
| 07/18/2000 | US6090578 Composition comprising at least 75% w/w of human multiple tumor suppressor 1 polypeptide; diagnosis of predisposition for cancer; anticarcinogenic agents; gene therapy |
| 07/18/2000 | US6090576 Nucleotide and amino acid sequences; for diagnosis of infections, immunogens, and vaccines especially against otitis media |
| 07/18/2000 | US6090574 Process for preparing a protein by a fungus transformed by multicopy integration of an expression vector |
| 07/18/2000 | US6090564 Amino acid sequence of human small nuclear ribonucleoprotein protein; for diagnosis, prevention and treatment of systemic lupus erythematosus |
| 07/18/2000 | US6090554 Efficient construction of gene targeting vectors |
| 07/18/2000 | US6090543 Cleavage of nucleic acids |
| 07/18/2000 | US6090382 Human antibodies that bind human TNFα |
| 07/18/2000 | CA2175797C Human kunitz-type protease inhibitors |
| 07/18/2000 | CA2162689C Immunotoxins comprising gelonin and an antibody |
| 07/18/2000 | CA2011031C Plasmodium merozoite rhoptries antigen and derivatives thereof |
| 07/18/2000 | CA1341052C Cellular encapsulation of biological pesticides |
| 07/13/2000 | WO2000040745A1 Prokaryotic system designed to monitor protease activity |
| 07/13/2000 | WO2000040737A1 High efficiency mammalian gene expression vectors that contain exogenous promoter and entire 5' untranslated region in the upstream from start codon for inherent gene as transcription regulatory site |
| 07/13/2000 | WO2000040736A2 Molecular-biological marker for analytical electron microscopy |
| 07/13/2000 | WO2000040733A1 Human cyclic nucleotide pdes |
| 07/13/2000 | WO2000040732A1 Variant luciferase, variant luciferase gene, novel recombinant dna and process for producing variant luciferase |
| 07/13/2000 | WO2000040731A1 Thermostable firefly luciferases, thermostable firefly luciferase genes, novel recombinant dna and process for producing thermostable firefly luciferase |
| 07/13/2000 | WO2000040729A1 Streptococcal abc transporter protein |
| 07/13/2000 | WO2000040728A1 Nucleic acids and proteins corresponding to mutants of g-csf with granulopoietic activity |
| 07/13/2000 | WO2000040727A2 Recombinant growth factor with the biological activity of a g-csf (granulocyte colony stimulating factor) |
| 07/13/2000 | WO2000040722A2 Insulin-synthesis genes |
| 07/13/2000 | WO2000040721A1 Monocyte-derived nucleic acids and related compositions and methods |
| 07/13/2000 | WO2000040717A1 Method for the cellular high-throughput-detection of nuclear receptor ligand interactions |
| 07/13/2000 | WO2000040716A2 Soluble receptor br43x2 and methods of using them for therapy |
| 07/13/2000 | WO2000040708A1 Thermostable creatine amidinohydrolase and process for producing the same |
| 07/13/2000 | WO2000040707A1 Modified forms of hepatitis c virus ns3 protease |
| 07/13/2000 | WO2000040705A2 Human desaturase gene and uses thereof |
| 07/13/2000 | WO2000040698A1 Pth receptor and screening assay utilizing the same |
| 07/13/2000 | WO2000040696A1 Preservation of sensitive biological materials at ambient temperatures by vitrification |
| 07/13/2000 | WO2000040666A1 Process and composition for treating hydrocarbon contaminated material |
| 07/13/2000 | WO2000040616A1 METHODS OF ELICITING BROADLY NEUTRALIZING ANTIBODIES TARGETING HIV-1 gp41 |
| 07/13/2000 | WO2000040614A2 Characterization of the soc/crac calcium channel protein family |
| 07/13/2000 | WO2000040609A1 Novel protein |
| 07/13/2000 | WO2000040607A2 Tiam2 (t-cell lymphoma invasion and metastasis 2) nucleotide exchange factor |
| 07/13/2000 | WO2000040603A2 Production of recombinant monellin using methylotrophic yeast expression system |
| 07/13/2000 | WO2000040594A1 AcpS |
| 07/13/2000 | WO2000021987A3 A method of identifying modulators of cell surface membrane receptors useful in the treatment of disease |
| 07/13/2000 | WO2000021986A3 Matrix-remodeling genes |
| 07/13/2000 | WO2000015799A3 Rna-associated proteins |
| 07/13/2000 | WO2000012735A9 Transgene assay using stable agrobacterium rhizogenes transformation |
| 07/13/2000 | WO2000012705A9 Methods for improving the function of heterologous g protein-coupled receptors |
| 07/13/2000 | WO2000010582A3 Probiotic, lactic acid-producing bacteria and uses thereof |
| 07/13/2000 | WO2000008196A9 Urate oxidase |
| 07/13/2000 | WO2000007545A9 Apoptosis proteins |
| 07/13/2000 | DE19900743A1 Neue komplexbildende Proteine New complexing proteins |
| 07/13/2000 | DE19900511A1 Molekularbiologische Marker für die analytische Elektronenmikroskopie Molecular biological marker for analytical electron microscopy |
| 07/13/2000 | DE19900446A1 Particulate dry baking yeast coated or encapsulated with starch so as to protect it form the effects of air and thus give retention of activity over prolonged periods |
| 07/13/2000 | DE19859887A1 Process to produce a continual supply of beer brewing yeast cells for rapid and active promotion of fermentation |
| 07/13/2000 | CA2753331A1 Soluble receptor br43x2 and methods of using |
| 07/13/2000 | CA2364005A1 Production of recombinant monellin using methylotrophic yeast expression system |
| 07/13/2000 | CA2360396A1 Characterization of a calcium channel family |
| 07/13/2000 | CA2360032A1 Preservation of sensitive biological materials at ambient temperatures by vitrification |
| 07/13/2000 | CA2360022A1 Prokaryotic system designed to monitor protease activity |
| 07/13/2000 | CA2359971A1 Modified forms of hepatitis c virus ns3 protease |
| 07/13/2000 | CA2359892A1 Methods of eliciting broadly neutralizing antibodies targeting hiv-1 gp41 |
| 07/13/2000 | CA2358562A1 Monocyte-derived nucleic acids and related compositions and methods |
| 07/13/2000 | CA2358543A1 Human desaturase gene and uses thereof |
| 07/13/2000 | CA2357996A1 Streptococcal abc transporter protein |
| 07/13/2000 | CA2357811A1 Nucleic acids and proteins corresponding to mutants of g-csf with granulopoietic activity |
| 07/13/2000 | CA2357677A1 Insulin-synthesis genes |
| 07/13/2000 | CA2357146A1 Human cyclic nucleotide pdes |
| 07/13/2000 | CA2293875A1 Use of spore adhesion assays in fungicide screening |
| 07/12/2000 | EP1018558A2 Hepatitis C Virus Epitopes |
| 07/12/2000 | EP1018557A2 Infectious cDNA clone of north american porcine reproductive and respiratory syndrome (PRRS) virus and uses thereof |
| 07/12/2000 | EP1018556A1 Chimeric and/or growth-restricted flaviviruses |
| 07/12/2000 | EP1018555A2 Chimeric papilomavirus-like particles |
| 07/12/2000 | EP1018552A1 Production of pluripotent granulocyte colony-stimulating factor |
| 07/12/2000 | EP1018551A1 Megsin protein |
| 07/12/2000 | EP1018550A2 Allergenic protein and peptides from house dust mite and uses thereof |
| 07/12/2000 | EP1018545A1 Microbial agricultural chemical |
| 07/12/2000 | EP1018511A1 Isochroman compounds and their production process |
| 07/12/2000 | EP1018341A1 Antistress agents and functional foods |
| 07/12/2000 | EP1017853A1 Normalized nucleic acid libraries and methods of production thereof |
| 07/12/2000 | EP1017846A1 Control of immune responses by modulating activity of glycosyltransferases |
| 07/12/2000 | EP1017840A1 NOVEL $i(SERRATIA MARCESCENS) STRAIN, PRODIGIOSIN AND THE USE OF THE SAME AS AN IMMUNOSUPPRESSIVE |
| 07/12/2000 | EP1017837A1 Retroviral vectors comprising a functional splice donor site and a functional splice acceptor site |
| 07/12/2000 | EP1017834A1 Methods for coexpression of more than one gene using at least one internal ribosome entry site (ires) |
| 07/12/2000 | EP1017828A1 HUMAN COMPLEMENT C3-DEGRADING PROTEINASE FROM $i(STREPTOCOCCUS PNEUMONIAE) |
| 07/12/2000 | EP1017827A1 New human cathepsin |
| 07/12/2000 | EP1017826A2 Compositions and methods for identifying pkb kinase inhibitors |
| 07/12/2000 | EP1017822A1 $i(LKTA) DELETION MUTANT OF $i(P. HAEMOLYTICA) |
| 07/12/2000 | EP1017821A1 IMPROVED $i(ENTEROBACTERIACEAE) FERMENTATION STRAINS |
| 07/12/2000 | EP1017818A2 Macrophage derived chemokine (mdc), mdc analogs, mdc inhibitor sustances, and uses thereof |
| 07/12/2000 | EP1017816A1 Insulin-like polypeptide and uses therefor |
| 07/12/2000 | EP1017811A1 G-protein coupled glycoprotein hormone receptor hg38 |
| 07/12/2000 | EP1017809A2 Human regulatory molecules |
| 07/12/2000 | EP1017808A2 53bp2 complexes |
| 07/12/2000 | EP1017807A1 Osf2/cbfa1 compositions and methods of use |
| 07/12/2000 | EP1017806A2 Compositions and methods for conferring tick immunity and preventing tick borne diseases |
| 07/12/2000 | EP1017803A1 Expression of endogenous genes by non-homologous recombination of a vector construct with cellular dna |
| 07/12/2000 | EP1017802A1 A potential effector for the grb7 family of signalling proteins |
| 07/12/2000 | EP1017792A1 Recombinant materials and methods for the production of limonene hydroxylases |
| 07/12/2000 | EP1017787A1 Recombinant yeast cell and assay using same |
| 07/12/2000 | EP1017786A1 I-(kappa)- b(kinases) |
| 07/12/2000 | EP1017784A1 Lyse eines mikroorganismuses |
| 07/12/2000 | EP1017721A1 Recombinant mhc molecules useful for manipulation of antigen-specific t-cells |
| 07/12/2000 | EP1017717A1 Isolated proteins having retinol dehydrogenase activity, and which associate with retinol binding protein receptors |
| 07/12/2000 | EP1017712A1 Ucp3 genes |
| 07/12/2000 | EP1017707A1 29 human secreted proteins |